View the Whatcom County Respiratory Virus Dashboard Here
The new adjuvanted (2023–2204) formulation of Novavax COVID-19 vaccine is authorized for people 12 years or older as follows: Updated 2023–2024 COVID-19 vaccine availability may be limited and vary by location. Help patients understand this situation and thank them for their patience. Resources Questions?
This 2023–2024 respiratory illness season, we’re monitoring 3 common causes of respiratory illness that circulate in Whatcom County: influenza, respiratory syncytial virus (RSV), and COVID-19. Influenza Centers for Disease Control and Prevention (CDC) estimates that in the United States last flu season (2022–2023) caused: Those at highest risk for severe illness include: Guidelines RSV RSV … 09/28/23 Health Advisory: 2023–2024 Respiratory Illness Season
FDA deauthorized previous bivalent COVID-19 vaccines. On Sept. 11, 2023, FDA deauthorized previous bivalent COVID-19 vaccines from Moderna and Pfizer. CDC recommends new, updated (2023–2024) COVID-19 vaccines. CDC’s new, updated (2023–2014) COVID-19 vaccine recommendations: Vaccination remains the best way to prevent COVID-19 hospitalization and death and reduces the risk of long COVID. The new, updated … 09/21/23 Health Advisory: New COVID-19 Vaccines Authorized, Previous Bivalent COVID-19 Vaccines Deauthorized
A Pierce County man was diagnosed July 13 with colonization due to Candida auris (C. auris), a multidrug-resistant fungus that can cause serious infections. This is believed to be the first locally acquired case in Washington. C. auris is a type of yeast that can cause severe illness, especially in those suffering from serious medical conditions who have … 07/19/23: The first case of Candida auris diagnosed in Washington
Penicillin G benzathine (Bicillin L-A) is in short supply due to increased demand. Syphilis is increasing in all groups, especially in heterosexual people. Reserve Bicillin L-A for pregnant people with or exposed to syphilis, or babies with congenital syphilis. Read on for syphilis: Treatment. Testing with reverse algorithm. Reserve Bicillin L-A for pregnant people. Reserve … 07/06/23 Health Advisory: Syphilis Treatment Impacted by Bicillin L-A Shortage
Requested actions Background Shigellosis is an acute enteric infection. It is an important cause of domestically acquired and travel-associated bacterial diarrhea in the United States. A low infectious dose makes Shigella bacteria easily transmitted from person to person. Consider shigellosis in the differential diagnosis of acute diarrhea, especially in people who: Shigellosis can be a mild, … 03/14/23 Health Advisory: Extensively Drug-Resistant Shigellosis
Actions requested Background Washington State Department of Health (DOH) and Centers for Disease Control and Prevention (CDC) are investigating a cluster of antibiotic-resistant infections that may be linked to artificial tears. The most frequently reported brand was EzriCare Artificial Tears, a preservative-free product dispensed in muti-dose bottles. These over-the-counter eye drops are sold widely in … 02/03/23 Health Advisory: Multistate Cluster of Antibiotic Resistant Bacteria Associated with Artificial Tears
Be advised: Background Seasonal flu activity is high across the United States. Vaccination and antiviral treatment help prevent and control flu. U.S. Food and Drug Administration (FDA) approved 4 antivirals for early treatment of outpatients with flu: oseltamivir, baloxavir, zanamivir and peramivir. While FDA does not report shortages of oseltamivir in any of its forms, providers … 12/19/22 Health Advisory: Antiviral Flu Treatment Interim Guidance
On April 21, 2022, President Biden announced a new Uniting for Ukraine (U4U) process to help Ukrainian citizens fleeing war come to the United States temporarily. As of Nov. 18, 2022: Newly arrived Ukrainian citizens have various medical and mental health needs. Resources
Bebtelovimab no longer authorized in the United States. On Nov. 30, 2022, U.S. Food and Drug Administration (FDA) revoked its Emergency Use Authorization (EUA) for bebtelovimab. Bebtelovimab is a monoclonal antibody used to treat COVID-19. FDA revoked the EUA because the drug lost efficacy against most SARS-CoV-2 variants currently circulating in the United States. Currently, … 12/12/22 Health Advisory: COVID-19 Therapeutics Updates
